Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018

Randomised controlled trials have shown a neutral or even unfavourable risk–benefit balance of aspirin for primary prevention of cardiovascular events. Using Danish nationwide registries, we investigated aspirin use and associated risks during the past two decades (1998–2018). We linked individual p...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Mikkel B., Jimenez-Solem, Espen, Ernst, Martin. T., Schmidt, Morten, Pottegård, Anton, Grove, Erik L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245534/
https://www.ncbi.nlm.nih.gov/pubmed/34193948
http://dx.doi.org/10.1038/s41598-021-93179-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245534/
https://www.ncbi.nlm.nih.gov/pubmed/34193948
http://dx.doi.org/10.1038/s41598-021-93179-8

Ejemplares similares